SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-013838
Filing Date
2022-08-22
Accepted
2022-08-22 09:00:38
Documents
15
Period of Report
2022-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fencf-20220822x8k.htm   iXBRL 8-K 53395
2 EX-4.1 fencf-20220822xex4d1.htm EX-4.1 461250
3 EX-99.1 fencf-20220822xex99d1.htm EX-99.1 25375
4 GRAPHIC fencf-20220822xex99d1001.jpg GRAPHIC 2794
  Complete submission text file 0001558370-22-013838.txt   759854

Data Files

Seq Description Document Type Size
5 EX-101.SCH fencf-20220822.xsd EX-101.SCH 3047
6 EX-101.LAB fencf-20220822_lab.xml EX-101.LAB 16030
7 EX-101.PRE fencf-20220822_pre.xml EX-101.PRE 10419
9 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20220822x8k_htm.xml XML 4874
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 221182342
SIC: 2836 Biological Products, (No Diagnostic Substances)